vs

Side-by-side financial comparison of NexPoint Real Estate Finance, Inc. (NREF) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

NexPoint Real Estate Finance, Inc. is the larger business by last-quarter revenue ($11.1M vs $8.7M, roughly 1.3× Wave Life Sciences Ltd.). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -580.2%, a 796.8% gap on every dollar of revenue. On growth, NexPoint Real Estate Finance, Inc. posted the faster year-over-year revenue change (-48.8% vs -55.8%).

NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

NREF vs WVE — Head-to-Head

Bigger by revenue
NREF
NREF
1.3× larger
NREF
$11.1M
$8.7M
WVE
Growing faster (revenue YoY)
NREF
NREF
+7.0% gap
NREF
-48.8%
-55.8%
WVE
Higher net margin
NREF
NREF
796.8% more per $
NREF
216.6%
-580.2%
WVE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
NREF
NREF
WVE
WVE
Revenue
$11.1M
$8.7M
Net Profit
$24.0M
$-50.5M
Gross Margin
Operating Margin
-606.5%
Net Margin
216.6%
-580.2%
Revenue YoY
-48.8%
-55.8%
Net Profit YoY
58.7%
-53.3%
EPS (diluted)
$0.47
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NREF
NREF
WVE
WVE
Q4 25
$11.1M
Q3 25
$12.5M
Q2 25
$12.1M
$8.7M
Q1 25
$11.5M
$9.2M
Q4 24
$21.7M
Q3 24
$12.5M
Q2 24
$6.7M
$19.7M
Q1 24
$-12.8M
$12.5M
Net Profit
NREF
NREF
WVE
WVE
Q4 25
$24.0M
Q3 25
$50.9M
Q2 25
$22.3M
$-50.5M
Q1 25
$26.0M
$-46.9M
Q4 24
$15.2M
Q3 24
$23.3M
Q2 24
$12.1M
$-32.9M
Q1 24
$-14.6M
$-31.6M
Operating Margin
NREF
NREF
WVE
WVE
Q4 25
Q3 25
Q2 25
-606.5%
Q1 25
-542.8%
Q4 24
Q3 24
Q2 24
-177.7%
Q1 24
-274.8%
Net Margin
NREF
NREF
WVE
WVE
Q4 25
216.6%
Q3 25
407.0%
Q2 25
184.5%
-580.2%
Q1 25
225.6%
-510.9%
Q4 24
69.9%
Q3 24
186.4%
Q2 24
179.7%
-167.2%
Q1 24
114.3%
-251.7%
EPS (diluted)
NREF
NREF
WVE
WVE
Q4 25
$0.47
Q3 25
$1.14
Q2 25
$0.54
$-0.31
Q1 25
$0.70
$-0.29
Q4 24
$0.71
Q3 24
$0.74
Q2 24
$0.40
$-0.25
Q1 24
$-0.83
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NREF
NREF
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$31.1M
$208.5M
Total DebtLower is stronger
$771.2M
Stockholders' EquityBook value
$388.0M
$139.3M
Total Assets
$5.3B
$252.4M
Debt / EquityLower = less leverage
1.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NREF
NREF
WVE
WVE
Q4 25
$31.1M
Q3 25
$17.9M
Q2 25
$9.1M
$208.5M
Q1 25
$19.2M
$243.1M
Q4 24
$3.9M
Q3 24
$34.7M
Q2 24
$4.3M
$154.0M
Q1 24
$13.5M
$180.9M
Total Debt
NREF
NREF
WVE
WVE
Q4 25
$771.2M
Q3 25
$720.9M
Q2 25
$815.6M
Q1 25
$831.5M
Q4 24
$799.3M
Q3 24
$815.5M
Q2 24
$861.0M
Q1 24
$843.3M
Stockholders' Equity
NREF
NREF
WVE
WVE
Q4 25
$388.0M
Q3 25
$375.4M
Q2 25
$348.2M
$139.3M
Q1 25
$343.7M
$171.8M
Q4 24
$336.5M
Q3 24
$335.8M
Q2 24
$327.5M
$-3.5M
Q1 24
$327.1M
$25.4M
Total Assets
NREF
NREF
WVE
WVE
Q4 25
$5.3B
Q3 25
$5.3B
Q2 25
$5.4B
$252.4M
Q1 25
$5.4B
$288.3M
Q4 24
$5.4B
Q3 24
$5.7B
Q2 24
$6.6B
$208.8M
Q1 24
$7.1B
$235.3M
Debt / Equity
NREF
NREF
WVE
WVE
Q4 25
1.99×
Q3 25
1.92×
Q2 25
2.34×
Q1 25
2.42×
Q4 24
2.38×
Q3 24
2.43×
Q2 24
2.63×
Q1 24
2.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NREF
NREF
WVE
WVE
Operating Cash FlowLast quarter
$-4.5M
$-46.0M
Free Cash FlowOCF − Capex
$-46.3M
FCF MarginFCF / Revenue
-532.5%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
-0.19×
TTM Free Cash FlowTrailing 4 quarters
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NREF
NREF
WVE
WVE
Q4 25
$-4.5M
Q3 25
$8.1M
Q2 25
$3.3M
$-46.0M
Q1 25
$16.0M
$-63.0M
Q4 24
$4.4M
Q3 24
$14.7M
Q2 24
$-7.5M
$-27.5M
Q1 24
$17.7M
$-33.4M
Free Cash Flow
NREF
NREF
WVE
WVE
Q4 25
Q3 25
Q2 25
$-46.3M
Q1 25
$-63.2M
Q4 24
Q3 24
Q2 24
$-27.5M
Q1 24
$-33.8M
FCF Margin
NREF
NREF
WVE
WVE
Q4 25
Q3 25
Q2 25
-532.5%
Q1 25
-688.9%
Q4 24
Q3 24
Q2 24
-139.8%
Q1 24
-270.0%
Capex Intensity
NREF
NREF
WVE
WVE
Q4 25
Q3 25
Q2 25
3.5%
Q1 25
1.8%
Q4 24
Q3 24
Q2 24
0.3%
Q1 24
3.3%
Cash Conversion
NREF
NREF
WVE
WVE
Q4 25
-0.19×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.62×
Q4 24
0.29×
Q3 24
0.63×
Q2 24
-0.62×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons